Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bactroban 2% ointment
1310011M0BBAAAA
|
Bactroban (Topical) | Mupirocin | Skin | 2,856 |
|
Skinoren 20% cream
1306010B0BBAAAA
|
Skinoren | Azelaic acid | Skin | 2,853 |
|
Salicylic acid 26% gel
1307000M0AABMBM
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 2,823 |
|
Acnecide 5% gel
1306010C0BUAAAB
|
Acnecide | Benzoyl peroxide | Skin | 2,765 |
|
Calcitriol 3micrograms/g ointment
1305020W0AAAAAA
|
Calcitriol (Psoriasis) | Calcitriol | Skin | 2,762 |
|
Clotrimazole 1% spray
1310020H0AAAEAE
|
Clotrimazole (Topical) | Clotrimazole | Skin | 2,744 |
|
Tioconazole 283mg/ml medicated nail lacquer
1310020T0AAAAAA
|
Tioconazole | Tioconazole | Skin | 2,681 |
|
Driclor 20% solution
1312000C0BCAAAS
|
Driclor | Aluminium chloride | Skin | 2,636 |
|
Hydrocortisone 2.5% cream
1304000V0AAAFAF
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 2,624 |
|
Coal tar solution 5% cutaneous emulsion
1305020C0AACXCX
|
Coal tar/tar (Topical) | Tars | Skin | 2,607 |
|
Synalar 0.025% ointment
1304000N0BBAGBB
|
Synalar | Fluocinolone acetonide | Skin | 2,578 |
|
Salatac gel
1307000M0BJAAAV
|
Salatac | Salicylic acid | Skin | 2,553 |
|
Dermacolor camouflage creme
130802000BBATA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 2,531 |
|
Differin 0.1% gel
1306010H0BBAAAA
|
Differin | Adapalene | Skin | 2,437 |
|
Hydrex 4% Surgical Scrub
1311020L0BNABAI
|
Hydrex | Chlorhexidine gluconate | Skin | 2,421 |
|
Lyclear 5% dermal cream
1310040Q0BBABAB
|
Lyclear | Permethrin | Skin | 2,409 |
|
Fluorouracil 0.5% / Salicylic acid 10% cutaneous solution
1308010Y0AAABAB
|
Fluorouracil (Sunscreen) | Fluorouracil (Sunscreen) | Skin | 2,394 |
|
Betamethasone valerate 0.1% / Clioquinol 3% cream
1304000F0AACACA
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 2,376 |
|
Emulsiderm emollient
1302011M0BBAAAE
|
Emulsiderm | Liquid paraffin | Skin | 2,345 |
|
Hydrous ointment
1302010Y0AAAAAA
|
Hydrous | Wool alcohols | Skin | 2,339 |
|
Psoriderm scalp lotion
1309000C0BDAAAE
|
Psoriderm (Scalp) | Coal tar | Skin | 2,339 |
|
Vaniqa 11.5% cream
1309000X0BBAAAA
|
Vaniqa | Eflornithine monohydrate chloride | Skin | 2,332 |
|
Audavate RD 0.025% ointment
1304000F0BGAABB
|
Audavate | Betamethasone valerate | Skin | 2,299 |
|
Actikerall 5mg/g / 100mg/g cutaneous solution
1308010Y0BCAAAB
|
Actikerall (Sunscreen) | Fluorouracil (Sunscreen) | Skin | 2,293 |
|
Dermacool 0.5% cream
1303000AABCAAAA
|
Dermacool | Menthol | Skin | 2,267 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.